Tau Alzheimer biomarkers

Tau proteins are mainly present in neurons and play a role in axonal microtubule stability. An increase of Tau is considered as a biomarker for neuronal death and as such often included in diagnostic algorithms for Alzheimer’s disease.

The AT120, HT7 and BT2 monoclonal antibodies can be used for the development of (immuno) assays for quantification of Total Tau.

  • These materials are available to industrial partners for use in research or diagnostic kits.
  • Small quantities (for research use) can be purchased through ThermoFisher Scientific.
     

Read about how Fujirebio collaborates closely with the international clinical community and partner organizations to develop the neurodegeneration diagnostic tools of the future >> 

Contact sales for information
Please contact your local Fujirebio representative for the availability of this product in your country.

  • Insights

  • Product inquiry

    CAPTCHA

    The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

    For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

    If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: privacy@fujirebio.com.

    • Review past webinars

    Neurodegenerative diseases
    Replay available
    2026/03/03 - 10:00 AM EST / 16:00 CET

    Mapping Synaptic Loss: Where β‑synuclein Fits in the Biomarker Landscape

    Watch replay
    Neurodegenerative diseases
    Replay available
    2025/11/19 - 10:00 AM EST / 16:00 CET

    Unlocking the biology of dementia with Lewy bodies: Biomarker insights from DDC to synapses

    Watch replay
    Neurodegenerative diseases
    Replay available
    2021/11/18 - 18 November 2021

    Preparing for the future of plasma based Alzheimers disease diagnostics

    Watch replay

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.